分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Platelet Internalization Mediates Ferroptosis in Myocardial Infarction

Shuo Miao, Qingsong Zhang, Wei Ding, Bo Hou, Zhe Su, Mengyang Li, Lanting Yang, Jun Zhang, Wenguang Chang, Jianxun Wang

Journal:ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF:10.51

DOI:10.1161/ATVBAHA.122.318161

PMID:

Published:2022-11-10

research field:分子生物学细胞生物学心脏病学结构生物学

Abstract

Background: Myocardial cell death is the hallmark of myocardial infarction. In the process of myocardial injury, platelets contribute to the pathogenesis by triggering intense inflammatory responses. Yet, it is still unclear if platelets regulate cardiomyocyte death directly, thereby exacerbating myocardial injury in myocardial infarction. Methods: We describe a mechanism underlying the correlative association between platelets accumulation and myocardial cell death by using myocardial infarction mouse model and patient specimens. Results: Myocardial infarction induces platelets internalization, resulting in the release of miR-223-3p, a platelet-enriched miRNA. By targeting the ACSL3, miR-223-3p delivered by internalized platelets cause the reduction of stearic acid-phosphatidylcholine in cardiomyocytes. The presence of stearic acid-phosphatidylcholine protects cardiomyocytes against ferroptosis. Conclusions: Our work reveals a novel mechanism of platelet-mediated myocardial injury, highlighting antiplatelet therapies could potentially represent a multimechanism treatment of myocardial infarction, and implying ferroptosis being considered as novel target for therapeutics.

本文使用的Yeasen产品

购物车
客服
转染试用